Mometasone Furoate Patent Expiration

Mometasone Furoate is Used for treating nasal polyps in adult patients who have had ethmoid sinus surgery using a corticosteroid-eluting (mometasone furoate) implant. It was first introduced by Organon Llc A Sub Of Organon And Co in its drug Elocon on Apr 30, 1987. Other drugs containing Mometasone Furoate are Asmanex Hfa, Nasonex 24Hr Allergy, Nasonex, Sinuva, Asmanex Twisthaler. 18 different companies have introduced drugs containing Mometasone Furoate.


Mometasone Furoate Patents

Given below is the list of patents protecting Mometasone Furoate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sinuva US10232152 Systems, devices, and method for treating a sinus condition Nov 24, 2034 Intersect Ent Inc
Sinuva US10406332 Systems, devices, and method for treating a sinus condition Mar 13, 2034 Intersect Ent Inc
Sinuva US8763222 Methods and devices for crimping self-expanding devices Feb 08, 2032 Intersect Ent Inc
Sinuva US10357640 Expandable devices and methods for treating a nasal or sinus condition Oct 03, 2031 Intersect Ent Inc
Sinuva US8025635 Device and methods for treating paranasal sinus conditions Jun 12, 2027 Intersect Ent Inc
Sinuva US7544192 Sinus delivery of sustained release therapeutics Nov 29, 2026 Intersect Ent Inc
Sinuva US9585681 Device and methods for treating paranasal sinus conditions Apr 04, 2026 Intersect Ent Inc
Sinuva US7662141 Sinus delivery of sustained release therapeutics Mar 12, 2024

(Expired)

Intersect Ent Inc
Sinuva US7713255 Sinus delivery of sustained release therapeutics Mar 12, 2024

(Expired)

Intersect Ent Inc
Sinuva US7951130 Sinus delivery of sustained release therapeutics Mar 12, 2024

(Expired)

Intersect Ent Inc
Sinuva US7951131 Sinus delivery of sustained release therapeutics Mar 12, 2024

(Expired)

Intersect Ent Inc
Sinuva US7951133 Sinus delivery of sustained release therapeutics Mar 12, 2024

(Expired)

Intersect Ent Inc
Sinuva US8109918 Sinus delivery of sustained release therapeutics Mar 12, 2024

(Expired)

Intersect Ent Inc
Asmanex Twisthaler US6503537

(Pediatric)

Preparation of powder agglomerates Sep 17, 2018

(Expired)

Organon Llc
Asmanex Twisthaler US8173172

(Pediatric)

Preparation of powder agglomerates Sep 17, 2018

(Expired)

Organon Llc
Nasonex US6127353

(Pediatric)

Mometasone furoate monohydrate, process for making same and pharmaceutical compositions Apr 03, 2018

(Expired)

Organon Llc
Asmanex Twisthaler US6503537 Preparation of powder agglomerates Mar 17, 2018

(Expired)

Organon Llc
Asmanex Twisthaler US8173172 Preparation of powder agglomerates Mar 17, 2018

(Expired)

Organon Llc
Nasonex US6127353 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions Oct 03, 2017

(Expired)

Organon Llc
Asmanex Hfa US6068832 Chlorofluorocarbon-free mometasone furoate aerosol formulations Aug 27, 2017

(Expired)

Organon Llc
Asmanex Twisthaler US6240918

(Pediatric)

Powdered medication inhaler Aug 20, 2017

(Expired)

Organon Llc
Asmanex Twisthaler US6240918 Powdered medication inhaler Feb 20, 2017

(Expired)

Organon Llc
Asmanex Twisthaler US5829434

(Pediatric)

Inhaler for powdered medications May 03, 2016

(Expired)

Organon Llc
Asmanex Twisthaler US5829434 Inhaler for powdered medications Nov 03, 2015

(Expired)

Organon Llc
Asmanex Twisthaler US5687710

(Pediatric)

Inhaler for powdered medications having spiral deagglomeration chamber May 18, 2015

(Expired)

Organon Llc
Asmanex Twisthaler US5687710 Inhaler for powdered medications having spiral deagglomeration chamber Nov 18, 2014

(Expired)

Organon Llc
Asmanex Hfa US5889015

(Pediatric)

Use of mometasone furoate for treating lower airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Hfa US6057307

(Pediatric)

Use of mometasone furoate for treating airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Hfa US6365581

(Pediatric)

Use of mometasone furoate for treating airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US5889015

(Pediatric)

Use of mometasone furoate for treating lower airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6057307

(Pediatric)

Use of mometasone furoate for treating airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6365581

(Pediatric)

Use of mometasone furoate for treating airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6677322

(Pediatric)

Use of mometasone furoate for treating airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6949532

(Pediatric)

Use of mometasone furoate for treating airway passage and lung diseases Jul 27, 2014

(Expired)

Organon Llc
Nasonex US5837699

(Pediatric)

Use of mometasone furoate for treating upper airway passage diseases Jul 27, 2014

(Expired)

Organon Llc
Nasonex US6723713

(Pediatric)

Use of mometasone furoate for treating upper airway diseases Jul 27, 2014

(Expired)

Organon Llc
Asmanex Hfa US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Hfa US6057307 Use of mometasone furoate for treating airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Hfa US6365581 Use of mometasone furoate for treating airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6057307 Use of mometasone furoate for treating airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6365581 Use of mometasone furoate for treating airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6677322 Use of mometasone furoate for treating airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US6949532 Use of mometasone furoate for treating airway passage and lung diseases Jan 27, 2014

(Expired)

Organon Llc
Nasonex US5837699 Use of mometasone furoate for treating upper airway passage diseases Jan 27, 2014

(Expired)

Organon Llc
Nasonex US6723713 Use of mometasone furoate for treating upper airway diseases Jan 27, 2014

(Expired)

Organon Llc
Asmanex Twisthaler US5394868

(Pediatric)

Inhalation device for powdered medicaments Dec 25, 2012

(Expired)

Organon Llc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Mometasone Furoate's patents.

Given below is the list recent legal activities going on the following patents of Mometasone Furoate.

Activity Date Patent Number
Patent litigations
Email Notification 12 Apr, 2024 US8109918
Mail O.P. Petition Decision 12 Apr, 2024 US8109918
Mail-Record Petition Decision of Granted to Make Entity Status large 09 Apr, 2024 US8109918
O.P. Petition Decision 08 Apr, 2024 US8109918
Record Petition Decision of Granted to Make Entity Status large 08 Apr, 2024 US8109918
Payment of Maintenance Fee under 1.28(c) 13 Feb, 2024 US8109918
Petition Entered 13 Feb, 2024 US8109918
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 13 Feb, 2024 US8109918
Change in Power of Attorney (May Include Associate POA) 09 Feb, 2024 US8109918
Email Notification 09 Feb, 2024 US8109918


Mometasone Furoate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Mometasone Furoate Generic API Manufacturers

Several generic applications have been filed for Mometasone Furoate. The first generic version for Mometasone Furoate was by Padagis Us Llc and was approved on Mar 18, 2002. And the latest generic version is by Apotex Inc and was approved on Apr 23, 2024.

Given below is the list of companies who have filed for Mometasone Furoate generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Discontinued NASAL N/A Jun 14, 2023


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
East Hanover Amneal Pharmaceuticals LLC
Paterson Amneal Pharmaceuticals, Llc
Branchburg Amneal Pharmaceuticals, LLC
Glasgow Amneal Pharmaceuticals LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
Bridgewater Amneal Complex Products Research LLC
Piscataway Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
India
Hyderabad Amneal Oncology Private Limited
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.





2. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Prescription NASAL AB Apr 3, 2017





3. ANDA REPOSITORY

Anda Repository Llc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

cream Discontinued TOPICAL N/A Apr 18, 2007





4. APOTEX

Apotex Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Discontinued NASAL N/A Apr 23, 2024


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Etobicoke Apotex, Inc.
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Brantford Apotex Pharmachem Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre





5. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Prescription NASAL AB Mar 18, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





6. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

lotion Discontinued TOPICAL N/A Nov 21, 2007


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
South Plainfield Cosette Pharmaceuticals, Inc.
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC





7. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

lotion Discontinued TOPICAL N/A Nov 21, 2007


Manufacturing Plant Locations
New

Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.

Country City Firm Name
India
Andheri East, Mumbai Encube Ethicals Private Ltd
Ponda Encube Ethicals Pvt. Ltd.





8. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

lotion Prescription TOPICAL AB Nov 29, 2007





9. GLENMARK PHARMS INC

Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

(reference standard)

ointment Prescription TOPICAL AB May 28, 2008





10. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

lotion Prescription TOPICAL AB Aug 9, 2010





11. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

(reference standard)

lotion Prescription TOPICAL AB Apr 6, 2005


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





12. PADAGIS US

Padagis Us Llc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

ointment Prescription TOPICAL AB Mar 18, 2002


Manufacturing Plant Locations
New

Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.

Country City Firm Name
United States
Minneapolis Padagis US LLC





13. TARO

Taro Pharmaceuticals Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

lotion Prescription TOPICAL AB Mar 15, 2006


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





14. TORRENT

Torrent Pharmaceuticals Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

ointment Discontinued TOPICAL N/A Jul 13, 2018


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Bharuch Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
United States
Basking Ridge Torrent Pharma Inc.
Kalamazoo Torrent Pharma Inc.